Drug Safety
-
{
- All
- News
-
Delhi HC Issues Notice On Plea Seeking Time-Bound Safety Review Of Acidity Drug Ranitidine
The Delhi High Court on Wednesday issued notice on a Public Interest Litigation (PIL) seeking a time-bound and reasoned decision by the Centre on the safety of Ranitidine, a widely used acidity medication, amid concerns over the possible presence of a cancer-linked impurity in the drug.
-
Weight-Loss Injections Under Scrutiny: American Body Flags Contamination At Chinese GLP-1 Drug Plants
The FDA's actions against Chengdu Shengnuo Biopharm and Nanjing Chengong Pharmaceutical underscore the importance of sanitation, reliable documentation, supplier verification and quality-control systems in pharmaceutical manufacturing.
-
The Lancet Reports A Boom In Fake Obesity Drugs: What You Need To Know
A new Lancet report pinpoints that a boom in counterfeit obesity drugs is taking place. Here is what you need to know about the dangers that these drugs pose and why following the properly established medical guidance is key to being safe.
-
The Lancet Reports A Boom In Fake Obesity Drugs: What You Need To Know
A new Lancet report pinpoints that a boom in counterfeit obesity drugs is taking place. Here is what you need to know about the dangers that these drugs pose and why following the properly established medical guidance is key to being safe.
-
Almost Half Of Antibiotic Prescribing For Surgery Is Inappropriate, New Report Shows
Inappropriate antibiotic prescribing around the time of surgery and long-term prescribing in aged care are among a mixed bag of findings of a recent report into antibiotic use and resistance in Australia.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
World AMR Awareness Week 2025: Doctor Explains How Careful Prescribing Protects The Power Of Antibiotics
As antibiotic resistance rises globally, doctors warn that misuse and self-medication are weakening our most powerful drugs. For AMR Awareness Week 2025, an infectious-disease specialist explains how careful prescribing, stewardship and public awaren
-
World AMR Awareness Week 2025: Doctor Explains How Careful Prescribing Protects The Power Of Antibiotics
As antibiotic resistance rises globally, doctors warn that misuse and self-medication are weakening our most powerful drugs. For AMR Awareness Week 2025, an infectious-disease specialist explains how careful prescribing, stewardship and public awaren
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
Insects Allegedly Found Inside Glucon-D Packet in Uttar Pradesh
A packet of the energy drink 'Glucon-D' was allegedly found with insects in Uttar Pradesh, following which it was sent for examination.
-
Ranbaxy to pay $500 million in US lawsuit settlement
Drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the US Department of Justice.
-
Delhi HC Issues Notice On Plea Seeking Time-Bound Safety Review Of Acidity Drug Ranitidine
The Delhi High Court on Wednesday issued notice on a Public Interest Litigation (PIL) seeking a time-bound and reasoned decision by the Centre on the safety of Ranitidine, a widely used acidity medication, amid concerns over the possible presence of a cancer-linked impurity in the drug.
-
Weight-Loss Injections Under Scrutiny: American Body Flags Contamination At Chinese GLP-1 Drug Plants
The FDA's actions against Chengdu Shengnuo Biopharm and Nanjing Chengong Pharmaceutical underscore the importance of sanitation, reliable documentation, supplier verification and quality-control systems in pharmaceutical manufacturing.
-
The Lancet Reports A Boom In Fake Obesity Drugs: What You Need To Know
A new Lancet report pinpoints that a boom in counterfeit obesity drugs is taking place. Here is what you need to know about the dangers that these drugs pose and why following the properly established medical guidance is key to being safe.
-
The Lancet Reports A Boom In Fake Obesity Drugs: What You Need To Know
A new Lancet report pinpoints that a boom in counterfeit obesity drugs is taking place. Here is what you need to know about the dangers that these drugs pose and why following the properly established medical guidance is key to being safe.
-
Almost Half Of Antibiotic Prescribing For Surgery Is Inappropriate, New Report Shows
Inappropriate antibiotic prescribing around the time of surgery and long-term prescribing in aged care are among a mixed bag of findings of a recent report into antibiotic use and resistance in Australia.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
World AMR Awareness Week 2025: Doctor Explains How Careful Prescribing Protects The Power Of Antibiotics
As antibiotic resistance rises globally, doctors warn that misuse and self-medication are weakening our most powerful drugs. For AMR Awareness Week 2025, an infectious-disease specialist explains how careful prescribing, stewardship and public awaren
-
World AMR Awareness Week 2025: Doctor Explains How Careful Prescribing Protects The Power Of Antibiotics
As antibiotic resistance rises globally, doctors warn that misuse and self-medication are weakening our most powerful drugs. For AMR Awareness Week 2025, an infectious-disease specialist explains how careful prescribing, stewardship and public awaren
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
Insects Allegedly Found Inside Glucon-D Packet in Uttar Pradesh
A packet of the energy drink 'Glucon-D' was allegedly found with insects in Uttar Pradesh, following which it was sent for examination.
-
Ranbaxy to pay $500 million in US lawsuit settlement
Drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the US Department of Justice.
